Incyte Announces Collaboration With Bristol Myers Squibb on Pancreatic Cancer Combination
Incyte says it will collaborate with Bristol Myers Squibb to evaluate a combination therapy for pancreatic cancer.
Incyte says it will collaborate with Bristol Myers Squibb to evaluate a combination therapy for pancreatic cancer.